{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-087933","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.069115+00:00","generated_at":"2026-06-08T01:17:35.268195+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"180 Life Sciences gets Nasdaq extension to Dec 15 for Rule 5635(d) compliance; new equity deficiency notice","bullets":["Nasdaq granted extension until Dec 15, 2023 to complete transactions to comply with Listing Rule 5635(d) regarding shareholder approval.","On Nov 15, 2023, Nasdaq notified noncompliance with minimum $2.5M stockholders' equity; company had ($149,327) deficit as of Sept 30, 2023.","Company must submit equity compliance plan by Jan 2, 2024; if accepted, may get up to 180 days extension.","Company also noncompliant with bid price rule and Rule 5635(d); failure could lead to delisting with appeal rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-087933","json":"https://secwatch.observer/filing/0001213900-23-087933.json","markdown":"https://secwatch.observer/filing/0001213900-23-087933.md","text":"https://secwatch.observer/filing/0001213900-23-087933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/0001213900-23-087933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/ea188599-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:17:35.268195+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6289eb2a606280816d84eac9ee8160483b264a0c","claim":"FORUM MARKETS Inc received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 15, 2023, the Company received a letter from Nasdaq notifying the Company that its stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ending September 30, 2023 (the “ Form 10-Q ”), did not meet the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Form 10-Q, the Company reported a stockholders’ deficit of ($149,327), which is below the minimum stockhol","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/0001213900-23-087933-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"f1b4bfc5d63cf82834a9786df41d8c1590ebe8b8","claim":"FORUM MARKETS Inc received a nasdaq noncompliance notice notice regarding shareholders (rules 5635(d)).","evidence_excerpt":"October 11, 2023, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it was not in compliance with the shareholder approval requirements set forth in Nasdaq Listing Rule 5635(d), which requires prior shareholder approval for transactions, other than public offerings, involving the issuance of 20% or more of the pre-transaction shares outstanding at less than the applicable Minimum Price (as defined in Listing Rule 5635(d)(1)(A)). The Staff’s determination under Listing Rule 5635(d) related to the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/0001213900-23-087933-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"shareholders"},{"label":"Rules","value":"5635(d)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}